ViGenCell Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	278.95	-	-	-
Cost of Revenue	281.11	0.84	3.45	2.9
Gross Profit	-2.17	-0.84	-3.45	-2.9
Selling, General & Admin	2,827	3,449	4,774	5,303
Research & Development	11,576	15,452	12,285	6,819
Other Operating Expenses	80.69	91.64	115.69	73.82
Operating Expenses	15,328	20,084	18,210	13,133
Operating Income	-15,330	-20,084	-18,214	-13,136
Interest Expense	-363.57	-399.27	-289.2	-352.68
Interest & Investment Income	795.02	2,248	1,219	99.41
Currency Exchange Gain (Loss)	-6.16	0.79	-8.35	1.29
Other Non Operating Income (Expenses)	-19.03	0.32	-1.7	2,105
EBT Excluding Unusual Items	-14,924	-18,234	-17,294	-11,283
Gain (Loss) on Sale of Investments	1,142	358.85	35.43	168.77
Gain (Loss) on Sale of Assets	-273.42	-	-135.12	-
Pretax Income	-14,056	-17,875	-17,393	-11,114
Net Income	-14,056	-17,875	-17,393	-11,114
Net Income to Common	-14,056	-17,875	-17,393	-11,114
Shares Outstanding (Basic)	19	19	19	17
Shares Outstanding (Diluted)	19	19	19	17
Shares Change (YoY)	0.79%	0.46%	10.20%	-
EPS (Basic)	-731.00	-937.00	-915.91	-645.96
EPS (Diluted)	-731.00	-937.00	-916.00	-758.98
Free Cash Flow	-11,008	-16,244	-24,743	-19,477
Free Cash Flow Per Share	-572.49	-851.46	-1302.97	-1130.20
Gross Margin	-0.78%	-	-	-
Operating Margin	-5495.85%	-	-	-
Profit Margin	-5038.78%	-	-	-
Free Cash Flow Margin	-3946.19%	-	-	-
EBITDA	-11,700	-15,987	-15,296	-11,417
D&A For EBITDA	3,631	4,098	2,918	1,718
EBIT	-15,330	-20,084	-18,214	-13,136
Advertising Expenses	-	2.54	17	13

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.